Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By boosting these receptors, https://tiannaerll509012.luwebs.com/36999587/tirzepatide-a-promising-new-treatment-for-obesity